STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

MACK MERRIMACK PHARMACEUTICALS INCORPORATED StockScouter® Report

3

StockScouter® Score

MERRIMACK PHARMACEUTICALS INCORPORATED, a small cap company in the healthcare sector, is expected to perform in line with the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The multi-period measure of relative price change and consistency is well above average. Positive

 

Concerns

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 80% done.
Progress: 60% done.
Low
High

Core Model Grades

C
C
N/A
A

Previous Ratings

8